Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 48651-48700 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05539560
The Effect of Olfactory Training in Patients With COVID-19 Induced Olfactory Dysfunction
NARecruiting
65 participants
Started: Jun 29, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05415020
Determining the Utility of a Behavioral Intervention in Chronic Migraine
NARecruiting
60 participants
Started: Jun 29, 2022 · Completed: Aug 14, 2026
6 conditions2 sponsors1 location
NCT05293470
A Post Marketing Surveillance on Piqray in Korea
N/ARecruiting
900 participants
Started: Jun 29, 2022 · Completed: May 12, 2027
1 condition1 sponsor17 locations
NCT06318559
Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention
NARecruiting
120 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors2 locations
NCT05408715
A Natural History Study in Children With a Type II Collagen Disorder With Short Stature
N/ARecruiting
60 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor2 locations
NCT05492721
Comparing Tissue Adhesives in Port Site Closure
PHASE3Recruiting
184 participants
Started: Jun 29, 2022 · Completed: Oct 29, 2025
1 condition1 sponsor1 location
NCT04780646
Effects of Urban Nature on Stress and Quality of Life
NARecruiting
93 participants
Started: Jun 29, 2022 · Completed: Dec 15, 2024
1 condition1 sponsor1 location
NCT05239858
International Wilson's Disease Patient Registry (iWilson Registry)
N/ARecruiting
500 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors16 locations
NCT05373940
Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years
NARecruiting
730 participants
Started: Jun 29, 2022 · Completed: May 31, 2030
3 conditions2 sponsors19 locations
NCT05530759
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
N/ARecruiting
50 participants
Started: Jun 29, 2022 · Completed: Apr 7, 2028
2 conditions1 sponsor1 location
NCT05405673
Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia
N/ARecruiting
2,500 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2025
3 conditions11 sponsors1 location
NCT04859764
Effect of Reparel Knee Sleeve with Knee Injection
NARecruiting
74 participants
Started: Jun 29, 2022 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT05516212
Caffeine Kinetics and CrossFit®-Specific Performance
PHASE2/PHASE3Recruiting
25 participants
Started: Jun 29, 2022 · Completed: Jul 30, 2024
4 conditions3 sponsors1 location
NCT04678869
CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)
NARecruiting
1,052 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2031
1 condition2 sponsors14 locations
NCT06714149
Impacts of Nitrogen Deposition in the Natural Environment on Pollen Allergy in Belgium
NARecruiting
200 participants
Started: Jun 29, 2022 · Completed: Apr 30, 2025
1 condition5 sponsors1 location
NCT05283044
Implementing Precision Medicine in cOmmunity HospiTALs
NARecruiting
10,000 participants
Started: Jun 29, 2022 · Completed: Apr 15, 2030
1 condition1 sponsor21 locations
NCT06317428
NT-proBNP Levels During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.
N/ARecruiting
29 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05119556
Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease
NARecruiting
768 participants
Started: Jun 28, 2022 · Completed: Jul 31, 2028
1 condition2 sponsors15 locations
NCT05139277
Evaluation of the CONVIVO System
NARecruiting
30 participants
Started: Jun 28, 2022 · Completed: Jun 30, 2025
6 conditions2 sponsors1 location
NCT05785208
Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status.
PHASE4Recruiting
122 participants
Started: Jun 28, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor11 locations
NCT06322173
Molecular Diagnostics of Bacterial Infections and Antibiotic Resistance in Blood Samples and Rectal Swabs Using Advanced NGS Sequencing Methods
NARecruiting
100 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04901169
Angiotensin II in Liver Transplantation
PHASE2/PHASE3Recruiting
50 participants
Started: Jun 28, 2022 · Completed: Sep 1, 2026
2 conditions2 sponsors1 location
NCT05113368
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
PHASE2Recruiting
31 participants
Started: Jun 28, 2022 · Completed: Feb 28, 2027
2 conditions2 sponsors1 location
NCT05388227
Pole Walking Intervention in Retirement Communities
NARecruiting
50 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT05695352
Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days
PHASE2Recruiting
21 participants
Started: Jun 28, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT06308692
Molecular Diagnostics of Bacterial Infections and Antibiotic Resistance in Blood Samples and Rectal Swabs Using Real Time PCR-ARES PCR Methods
NARecruiting
100 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05335252
Dronabinol After Arthroscopic Surgery
PHASE3Recruiting
30 participants
Started: Jun 28, 2022 · Completed: Jun 30, 2027
8 conditions1 sponsor1 location
NCT04539392
Assessment of the Sexuality of the Infertile Couple
N/ARecruiting
80 participants
Started: Jun 28, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05058651
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
PHASE2/PHASE3Recruiting
189 participants
Started: Jun 28, 2022 · Completed: Oct 1, 2028
4 conditions1 sponsor228 locations
NCT06284161
QCT in ALS Diagnosis, Mechanistic Understanding and Follow-up
NARecruiting
30 participants
Started: Jun 28, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05025813
Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma
PHASE2Recruiting
27 participants
Started: Jun 28, 2022 · Completed: Jun 1, 2027
2 conditions2 sponsors3 locations
NCT05413759
RhEumatoid Arthritis MEDIcation Adherence
NARecruiting
200 participants
Started: Jun 28, 2022 · Completed: Dec 28, 2027
1 condition1 sponsor2 locations
NCT05312281
Study Comparing Postoperative Treatment After Surgical Decompression for Lumbar Spinal Stenosis.
NARecruiting
100 participants
Started: Jun 28, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05903469
Implicit and Explicit Assessment of Suicide Risk
NARecruiting
108 participants
Started: Jun 28, 2022 · Completed: Jan 31, 2026
4 conditions2 sponsors1 location
NCT05312255
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
NARecruiting
175 participants
Started: Jun 28, 2022 · Completed: Jun 28, 2027
4 conditions1 sponsor1 location
NCT05754814
SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes
N/ARecruiting
100 participants
Started: Jun 28, 2022 · Completed: Apr 30, 2026
3 conditions3 sponsors2 locations
NCT05318105
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
NARecruiting
372 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor17 locations
NCT04781491
Effects of Nature and Forest Therapy in Patients With Metabolic Syndrome and Cardiovascular Risk Factors
NARecruiting
100 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04763343
Ketamine Treatment of Youth Suicide Attempters
PHASE3Recruiting
60 participants
Started: Jun 27, 2022 · Completed: Aug 31, 2026
1 condition4 sponsors2 locations
NCT07016997
A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors.
PHASE1Recruiting
70 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT05449496
Dietary Intervention to Improve Kidney Transplant Outcomes
NARecruiting
120 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2025
8 conditions2 sponsors1 location
NCT05580614
Paired tVNS With ERP in OCD
NARecruiting
56 participants
Started: Jun 27, 2022 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05412381
PRP in ACLR to Prevent PTOA
PHASE3Recruiting
56 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT03825835
30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
NARecruiting
1,200 participants
Started: Jun 27, 2022 · Completed: Dec 30, 2027
3 conditions15 sponsors19 locations
NCT05491395
Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction
NARecruiting
120 participants
Started: Jun 27, 2022 · Completed: May 1, 2029
1 condition1 sponsor1 location
NCT05511792
Down Sizing Strategy (HANGZHOU Solution) vs Standard Sizing Strategy TAVR in Bicuspid Aortic Stenosis (Type 0)
NARecruiting
206 participants
Started: Jun 27, 2022 · Completed: Jun 30, 2030
1 condition1 sponsor15 locations
NCT06743412
Passive Music Listening in Acute Cerebrovascular Disease
NARecruiting
150 participants
Started: Jun 27, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05887973
Addressing Root Causes for Gun Violence Prevention (ARC-GVP)
N/ARecruiting
250 participants
Started: Jun 27, 2022 · Completed: Jul 31, 2026
4 conditions2 sponsors1 location
NCT05312671
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
PHASE2Recruiting
63 participants
Started: Jun 27, 2022 · Completed: Oct 31, 2029
3 conditions2 sponsors2 locations
NCT05467527
PACT Programme for Parents of Children With SHCN
NARecruiting
196 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2025
8 conditions3 sponsors2 locations